• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FPR
Click for more information
0.33% $3.03

FLEETPARTNERS GROUP LIMITED - News & Media

Market Cap $725.1M  ! watchlist Created with Sketch. Add to my watchlist
Financial Services Credit Services

FleetPartners Group Limited is a provider of vehicle leasing, fleet management, heavy... FleetPartners Group Limited is a provider of vehicle leasing, fleet management, heavy commercial vehicles, salary packaging and novated leasing, operating across Australia and New Zealand. Its segments include Australia Commercial, Novated and New Zealand Commercial. The Australia Commercial segment specializes in fleet leasing and management. It operates under the trading names of FleetPlus and FleetPartners. The Novated segment specializes in novated leasing and salary packaging. It operates in Australia under the trading names of FleetPlus and FleetPartners. The New Zealand Commercial segment specializes in fleet leasing and management. It operates under the trading name of FleetPartners. Its products include a comprehensive range of motor vehicle fleet services, including vehicle acquisition, leasing, in-life fleet management and vehicle remarketing. Its fleet services include a fleet management platform, fuel management, vehicle branding, and accident management.More

No News & Media currently available.

(20min delay)
Last
$3.03 		Change
-0.010(0.33%) 		Mkt cap ! $725.1M
Open High Low Value Volume
$3.02 $3.04 $3.02 $59.29K 19.57K

Buyers (Bids)

No. Vol. Price($)
9 6576 $3.02
 

Sellers (Offers)

Price($) Vol. No.
$3.04 3376 15
View Market Depth
Last trade - 11.05am 02/10/2024 (20 minute delay) ?
Last
$3.03 		  Change
-0.010 ( 0.65 %)
Open High Low Volume
$3.03 $3.04 $3.02 4125
Last updated 11.23am 02/10/2024 ?
FPR (ASX) Chart

Top Stories

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
PainChek close to finding out if FDA approves its flagship app for use in dementia care PainChek (ASX:PCK) has updated the market on the progress of its De Novo submission to the US FDA for its flagship app in aged care settings.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.